Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Nucl Med Commun ; 35(10): 1032-7, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25014243

RESUMO

OBJECTIVE: Rubidium-82 (Rb-82) PET myocardial perfusion imaging (MPI) has superior diagnostic accuracy, at least similar prognostic value, and lower patient radiation exposure when compared with technetium-99m single-photon emission computed tomography (Tc-99m SPECT) MPI. The aim of this study was to compare occupational radiation exposure from the two modalities and show that improvements for the patient do not come at a cost to staff. MATERIALS AND METHODS: Electronic personal dosimeters were worn by staff involved in the administration and imaging of routine clinical Tc-99m SPECT and Rb-82 PET MPI, and during tracer production and QC. To estimate dose to the staff in the event of a medical emergency, a survey meter was placed in close contact with the patient during Rb-82 infusion and imaging, and immediately after administration for Tc-99m SPECT. RESULTS: Mean (SD) whole-body effective dose to staff during a single MPI procedure was 0.4 (0.4) µSv for Rb-82 PET (1110 MBq) and 3.3 (1.7) µSv for Tc-99m SPECT (350 MBq). Staff effective dose during tracer production and QC was low (<0.2 µSv/patient) and comparable between tracers. An additional effective dose was measured at close contact to the patient during, and immediately after, tracer administration, although this will not pose a significant radiation risk to staff with either technique as long as this is not routine practice. CONCLUSION: There is a significant reduction in effective dose during Rb-82 PET when compared with Tc-99m SPECT MPI because of the short half-life of Rb-82 and reduced patient contact.


Assuntos
Imagem de Perfusão do Miocárdio , Exposição Ocupacional/estatística & dados numéricos , Monitoramento de Radiação , Compostos Radiofarmacêuticos/efeitos adversos , Radioisótopos de Rubídio/efeitos adversos , Tecnécio/efeitos adversos , Tomografia Computadorizada de Emissão de Fóton Único , Pessoal de Saúde , Humanos , Imageamento por Ressonância Magnética , Radiometria , Compostos Radiofarmacêuticos/análise , Radioisótopos de Rubídio/análise , Tecnécio/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA